ARLINGTON, Va., Jan. 8, 2018 /PRNewswire/ -- Are you adapting to the new FDA guidance's?
Since the release of the 10th REMS Summit brochure, the FDA has released two guidances that amplify your need to attend the event that has every REMS professional talking. In light of these changes, we are excited to announce the expansion of the 10th Annual REMS Summit program to address the evolving REMS landscape!
BRAND NEW SESSIONS BY THE FDAOverview of Recent FDA Guidances Impacting REMS
Suzanne Robottom, Pharm.D., Regulatory Health Policy Analyst, Division of Risk Management, Office of Medication Error Prevention and Risk Management, Office of Surveillance and Epidemiology, FOOD AND DRUG ADMINISTRATION
Hot off the Press: New FDA Initiatives and Guidelines
Click here to see the fully updated agenda.
Thirty other speakers representing pharmaceutical companies, health systems, and regulatory agencies join Gita, Suzanne, and Annette on the 10th Annual REMS Summit speaking faculty. Connect with and learn from your industry peers at the REMS Summit on January 29–30 in Arlington, VA.
Register today to reserve your seat at the most anticipated REMS Summit yet! Save 15% off the standard rate when you use Discount Code C988PRNW
75+ ATTENDEES ALREADY REGISTERED!Join your peers from the following organizations and more.
AbbVieActelionBayerBiogenBioTrak ResearchCelgeneCO*REDukeEndoFDAGeisinger Health SystemGlobal ReachIndiviorJuno TherapeuticsLutoMcKessonMedicines for EuropeNorthwestern UniversityPfizerPPDSheehanShireUBCUNCZogenix
If you have any questions please reach out to Mercy Lister, Conference Producer, at [email protected].
Thank you to our 2018 sponsors!
BioTrakHaug PartnersMcKesson – McKesson Specialty HealthUBC – An Express Scripts Company
For more information, contact: ExL Events Phone: 866-207-6528 Email: [email protected]
Advertisement
Since the release of the 10th REMS Summit brochure, the FDA has released two guidances that amplify your need to attend the event that has every REMS professional talking. In light of these changes, we are excited to announce the expansion of the 10th Annual REMS Summit program to address the evolving REMS landscape!
Advertisement
BRAND NEW SESSIONS BY THE FDAOverview of Recent FDA Guidances Impacting REMS
- Introduce the new REMS document template
- Provide an overview of how to use a Drug Master File (DMF) for shared REMS submission
- Summarize the expected benefits of these guidances on REMS submissions
Suzanne Robottom, Pharm.D., Regulatory Health Policy Analyst, Division of Risk Management, Office of Medication Error Prevention and Risk Management, Office of Surveillance and Epidemiology, FOOD AND DRUG ADMINISTRATION
Hot off the Press: New FDA Initiatives and Guidelines
- Understand most current FDA guidelines about REMS
- Learn about current FDA initiatives on risk management
- Understand practical applications of new FDA initiatives
Click here to see the fully updated agenda.
Thirty other speakers representing pharmaceutical companies, health systems, and regulatory agencies join Gita, Suzanne, and Annette on the 10th Annual REMS Summit speaking faculty. Connect with and learn from your industry peers at the REMS Summit on January 29–30 in Arlington, VA.
Register today to reserve your seat at the most anticipated REMS Summit yet! Save 15% off the standard rate when you use Discount Code C988PRNW
75+ ATTENDEES ALREADY REGISTERED!Join your peers from the following organizations and more.
AbbVieActelionBayerBiogenBioTrak ResearchCelgeneCO*REDukeEndoFDAGeisinger Health SystemGlobal ReachIndiviorJuno TherapeuticsLutoMcKessonMedicines for EuropeNorthwestern UniversityPfizerPPDSheehanShireUBCUNCZogenix
If you have any questions please reach out to Mercy Lister, Conference Producer, at [email protected].
Thank you to our 2018 sponsors!
BioTrakHaug PartnersMcKesson – McKesson Specialty HealthUBC – An Express Scripts Company
For more information, contact: ExL Events Phone: 866-207-6528 Email: [email protected]
View original content:http://www.prnewswire.com/news-releases/fda-takes-the-stage-at-exls-10th-rems-summit-to-outline-fda-guidances-impacting-rems-300578308.html
SOURCE ExL Events